Synairgen plc (LON:SNG – Get Free Report)’s share price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 4.09 ($0.05) and traded as high as GBX 4.91 ($0.06). Synairgen shares last traded at GBX 4.58 ($0.06), with a volume of 473,712 shares changing hands.
Synairgen Trading Down 5.0 %
The company has a market capitalization of £8.76 million, a P/E ratio of -152.67 and a beta of -2.23. The business has a fifty day moving average price of GBX 4.09 and a 200 day moving average price of GBX 4.83. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Recommended Stories
- Five stocks we like better than Synairgen
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is the Nasdaq? Complete Overview with History
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- There Are Different Types of Stock To Invest In
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
